🟢 Edesa Biotech is trading 0% up in pre-market

Edesa Biotech is trading 0% up at $2.57, unchanged from its October 16 close, with no new company-specific catalyst identified for October 19.

• Supplied price data shows no pre-market gain, despite the alert headline reporting an 8.17% rise.
• The FDA cleared the Phase 2 vitiligo study IND on October 15; that earlier announcement is not evidence of a fresh catalyst today.
• Sector context is mixed: biotech is lower while major U.S. indices are higher.